Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AML in Remission”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00286845
What this trial is testing

Use of the MiCK Assay for Apoptosis in AML

Who this might be right for
Leukemia, Myelocytic, Acute
Pierian Biosciences 50
Early research (Phase 1)Looking for participantsNCT05010772
What this trial is testing

Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 125
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00957385
What this trial is testing

Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 24
Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Not applicableUnknownNCT00462657
What this trial is testing

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

Who this might be right for
Graft Versus Host DiseaseInfectionLeukemia+2 more
St. Bartholomew's Hospital 200
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Not applicableStudy completedNCT00005881
What this trial is testing

Quality of Life in Children Treated for Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 538
Testing effectiveness (Phase 2)Study completedNCT00002567
What this trial is testing

High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission

Who this might be right for
Bone Marrow AblationLeukemia
Memorial Sloan Kettering Cancer Center 45
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00534469
What this trial is testing

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

Who this might be right for
Leukemia
City of Hope Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00003991
What this trial is testing

Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Maxim Pharmaceuticals 360
Testing effectiveness (Phase 2)Ended earlyNCT00914940
What this trial is testing

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 41
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)Looking for participantsNCT06824168
What this trial is testing

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Who this might be right for
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo 130
Next Page